The nephropathy and CM-treated groups had a significant (p < 0.001) increase in the mean value of lipid peroxidation markers (MDA) and a decrease in the mean value of the antioxidant marker SOD, GPx, and CAT compared with the control group (Figure 4A–D). This evidence concerns the gene CAT and kidney disorder.